Alteration of epithelial integrity, Alkaline phosphatase activity, and fibronectin expression in lungs of rats exposed to ozone

Journal of Toxicology and Environmental Health - Part A

Volumn 57, Issue 5, 1999, Pages 329-343

  Bhalla, Deepak K ^a   Gupta, Suresh K ^a   Reinhart, Paul G ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; FIBRONECTIN; MESSENGER RNA; OZONE; PROTEIN;

AIR POLLUTANT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL TYPE; CONTROLLED STUDY; CYTOCHEMISTRY; ENZYME ACTIVITY; EPITHELIUM; EPITHELIUM CELL; INFLAMMATION; INFLAMMATORY CELL; LUNG; LUNG INJURY; LUNG LAVAGE; MACROPHAGE; MALE; MONONUCLEAR CELL; NEUTROPHIL; NONHUMAN; PERMEABILITY; PRIORITY JOURNAL; RAT;

AIR POLLUTANTS; ALKALINE PHOSPHATASE; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIUM; FIBRONECTINS; IN SITU HYBRIDIZATION; LUNG; MALE; OXIDANTS, PHOTOCHEMICAL; OZONE; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

ANIMALIA;

EID: 0032809093     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/009841099157647     Document Type: Article

References (34)

1. Begin, R., Martel, M., Desmarais, Y., Drapeau, G., Boileau, R., Rola-Pleszczynski, M., and Masse, S. 1986. Fibronectin and procollagen 3levels in bronchoalveolar lavage of asbestos-exposed human subjects and sheep. Chest 89:237-243.
2. Bhalla, D. K. 1999. Ozone induced lung inflammation and mucosal barrier disruption: Toxicology, mechanisms and implications. J. Toxicol. Environ. Health (B. Crit. Rev.) 2:31-86.
3. 3. An electron microscopic and autoradiographic analysis of the transport pathway. Am. Rev. Respir. Dis. 134: 572-579.
4. Bhalla, D. K., and Hoffman, L. 1997. Time course of airway epithelial and inflammatory changes in rats exposed to moderate l evels of ozone. Inhal. Toxicol. 9:829-842.
5. 3on rats: Sequence of epithelial and inflammatory changes in the distal airways. Inhal. Toxicol. 4:17-31.
6. Boudreau, J., Vincent, R., Nadeau, D., Trottier, B., Fournier, M., Krzystyniak, K., and Chevalier, G. 1988. Toxicity of inhaled cadmium chloride: Early responses of the antioxidant and surfactant systems in rat lungs. J. Toxicol. Environ. Health 23:241-256.
7. Dean, D. C. 1989. Expression of the fibronectin gene. Am. J. Respir. Cell Mol. Biol. 1:5-10.
8. DeChatelet, L. R., and Cooper, M. R. 1970. A modified procedure for the determination of leukocyte alkaline phosphatase. Biochem. Med. 4:61-68.
9. Denholm, E. M., Wolber, F. M., and Phan, S. H. 1989. Secretion of monocyte chemotactic activity by alveolar macrophages. Am. J. Pathol. 135:571-580.
10. Devlin, R. B., McDonnell, W. F., Mann, R., Becker, S., House, D. E., Schreinemachers, D., and Koren, H. S. 1991. Exposure of humans to ambient levels of ozone for 6.6hours causes cellular and biochemical changes in the lung. Am. J. Respir. Cell Mol. Biol. 4:72-81.
11. Devlin, R. B., McKinnon, K. P., Noah, T., Becker, S., and Koren, H. S. 1994. Ozone-induced release of cytokines and fibronectin by alveolar macrophages and airway epithelial cells. Am. J. Physiol. 266:L612-L619.
12. Driscoll, K. E., Maurer, J. K., Poynter, J., Higgins, J., Asquith, T., and Miller, N. S. 1992. Stimulation of rat alveolar macrophage fibronectin release in a cadmium chloride model of lung injury and fibrosis. Toxicol. Appl. Pharmacol. 116:30-37.
13. Esterline, R. L., Bassett, D. J. P., and Trush, M. A. 1989. Characterization of the oxidant generation by inflammatory cells lavaged from rat lungs following acute exposure to ozone. Toxicol. Appl. Pharmacol. 99:229-239.
14. Evans, M. J. 1984. Oxidant gases. Environ. Health Perspect. 55:85-95.
15. Everitt, E. A., Malik, A. B., and Hendey, B. 1996. Fibronectin enhances the migration rate of human neutrophils in vitro. J. Leukocyte Biol. 60:199-206.
16. Gomez-Lechon, M. J., and Castell, J. V. 1985. Enzyme-linked immunosorbent assay to quantify fibronectin. Anal. Biochem. 145:1-8.
17. Gupta, S. K., Reinhart, P. G., and Bhalla, D. K. 1998. Enhancement of fibronectin expression in rat lung by ozone and an inflammatory stimulus. Am. J. Physiol. 275(Lung Cell Mol. Physiol. 19): L330-L335.
18. Henderson, R. F., Rebar, A. H., DeNicola, D. B., Henderson, T. R., and Damon, E. G. 1981. The use of pulmonary washings as a probe to detect lung injury. Chest 80:12-15.
19. Henderson, R. F., Harkema, J. R., Hotchkiss, J. A., and Boehme, D. S. 1991. Effect of blood leucocyte depletion on the inflammatory response of the lung to quartz. Toxicol. Appl. Pharmacol. 109: 127-136.
20. Henderson, R. F., Scott, G. G., and Waide, J. J. 1995. Source of alkaline phosphatase activity in epithelial lining fluid of normal and injured F344rat lungs. Toxicol. Appl. Pharmacol. 134:170-174.
21. Johnson, K. J., Fantone, J. C. I., Kaplan, J., and Ward, P. A. 1981. In vivo damage of rat lungs by oxygen metabolites. J. Clin. Invest. 67:983-993.
22. Leikauf, G. D., Driscoll, K. E., and Wey, H. E. 1988. Ozone-induced augmentation of eicosanoid metabolism in epithelial cells from bovine trachea. Am. Rev. Respir. Dis. 137:435-442.
23. Limper, A. H., and Roman, J. 1992. Fibronectin. A versatile matrix protein with roles in thoracic development, repair and infection. Chest 101:1663-1673.
24. Madden, M. C., Eling, T. E., Dailey, L. A., and Friedman, M. 1991. The effect of ozone exposure on rat alveolar macrophage arachidonic acid metabolism. Exp. Lung Res. 17:47-63.
25. Pendino, K. J., Shuler, R. L., Laskin, J. D., and Laskin, D. L. 1994. Enhanced production of interleukin-1, tumor necrosis factor-alpha, and fibronectin by rat lung phagocytes following inhalation of a pulmonary i rritant. Am. J. Respir. Cell Mol. Biol. 11:279-286.
26. Peters, J. H., Ginsberg, M. H., Case, C. M., and Cochrane, C. G. 1988. Release of soluble fibronectin containing an extra type III domain (ED1) during acute pulmonary injury mediated by oxidants or leukocytes in vivo. Am. Rev. Respir. Dis. 138:167-174.
27. Pino, M. V., Stoval, M. Y., Levin, J. R., Devlin, R. B., Koren, H. S., and Hyde, D. M. 1992. Acute ozone-induced lung injury in neutrophil-depleted rats. Toxicol. Appl. Pharmacol. 114:268-276.
28. Rennard, S. I., and Crystal, R. G. 1982. Fibronectin in human bronchopulmonary lavage fluid. Elevation in patients with interstitial lung disease. J. Clin. Invest. 69:113-122.
29. Rennard, S. I., Hunninghake, G. W., Bitterman, P. B., and Crystal, R. G. 1981. Production of fibronectin by the human alveolar macrophage: Mechanism for the recruitment of fibroblasts to sites of tissue injury in interstitial l ung diseases. Proc. Natl. Acad. Sci. USA 78:7147-7151.
30. Roman, J., Limper, A. H., and McDonald, J. A. 1990. Lung extracellular matrix: Physiology and pathophysiology. Hosp. Pract. 25:125-140.
31. Ruoslahti, E. 1988. Fibronectin and its receptors. Annu. Rev. Biochem. 57:375-413.
32. Snyder, J. M., O'Brien, J. A., and Rodgers, H. F. 1987. Localization and accumulation of fibronectin in rabbit fetal lung tissue. Differentiation 34:32-39.
33. Song, W. D., Zhang, A. C., Pang, Y. Y., Liu, L. H., Zhao, J. Y., Deng, S. H., and Zhang, S. Y. 1995. Fibronectin and hyaluronan in bronchoalveolar lavage fluid from young patients with chronic obstructive pulmonary diseases. Respiration 62:125-129.
34. Thompson, P. N., Cho, E., Blumenstock, F. A., Shah, D. M., and Saba, T. M. 1992. Rebound elevation of fibronectin after tissue injury and ischemia: role of fibronectin synthesis. Am. J. Physiol. 263:G437-G445.